Hikal Limited – NSE:HIKAL.NS

Hikal Limited stock price today

INR 530
+148.55
+38.94%
Financial Health
0
1
2
3
4
5
6
7
8
9

Hikal Limited stock price monthly change

+5.83%
month

Hikal Limited stock price quarterly change

+5.83%
quarter

Hikal Limited stock price yearly change

+22.52%
year

Hikal Limited key metrics

Market Cap
45.16B
Enterprise value
54.58B
P/E
64.16
EV/Sales
3.00
EV/EBITDA
18.59
Price/Sales
2.58
Price/Book
3.91
PEG ratio
2.31
EPS
5.65
Revenue
17.79B
EBITDA
2.68B
Income
696M
Revenue Q/Q
-4.42%
Revenue Y/Y
-11.25%
Profit margin
4.04%
Oper. margin
6.82%
Gross margin
38.96%
EBIT margin
6.82%
EBITDA margin
15.12%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Hikal Limited stock price history

Hikal Limited stock forecast

Hikal Limited financial statements

Hikal Limited (NSE:HIKAL.NS): Profit margin
Jun 2023 3.86B 69.2M 1.79%
Sep 2023 4.31B 125.7M 2.91%
Dec 2023 4.47B 161.4M 3.61%
Mar 2024 5.14B 339.7M 6.61%
Hikal Limited (NSE:HIKAL.NS): Analyst Estimates
2026 22.95B 1.70B 7.45%
  • Analysts Price target

  • Financials & Ratios estimates

0.31%
Yield TTM
Hikal Limited (NSE:HIKAL.NS): Payout ratio
Payout ratio 0%
Hikal Limited (NSE:HIKAL.NS): Dividend Yield
2016 1.03%
2017 0.9%
2019 0.73%
2020 2.77%
2022 0.55%
Hikal Limited (NSE:HIKAL.NS): Debt to assets
Jun 2023 0 0
Sep 2023 23908500000 12.45B 52.1%
Dec 2023 0 0
Mar 2024 24871400000 12.99B 52.25%
Hikal Limited (NSE:HIKAL.NS): Cash Flow
Jun 2023 554.6M 0 0
Sep 2023 571.4M 0 0
Dec 2023 579.4M 0 0
Mar 2024 0 0 0

Hikal Limited alternative data

Hikal Limited (NSE:HIKAL.NS): Employee count
Aug 2023 1,906
Sep 2023 1,906
Oct 2023 2,142
Nov 2023 2,142
Dec 2023 2,142
Jan 2024 2,142
Feb 2024 2,142
Mar 2024 2,142
Apr 2024 2,142
May 2024 2,142
Jun 2024 2,142
Jul 2024 2,142

Hikal Limited other data

Insider Compensation
Mr. Sameer Hiremath (1974) MD & Director
$45,530,000
  • What's the price of Hikal Limited stock today?

    One share of Hikal Limited stock can currently be purchased for approximately $530.

  • When is Hikal Limited's next earnings date?

    Unfortunately, Hikal Limited's (HIKAL.NS) next earnings date is currently unknown.

  • Does Hikal Limited pay dividends?

    Yes, Hikal Limited pays dividends and its trailing 12-month yield is 0.31% with 0% payout ratio. The last Hikal Limited stock dividend of $0 was paid on 5 Sep 2025.

  • How much money does Hikal Limited make?

    Hikal Limited has a market capitalization of 45.16B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.34% to 17.85B US dollars.

  • What is Hikal Limited's stock symbol?

    Hikal Limited is traded on the NSE under the ticker symbol "HIKAL.NS".

  • What is Hikal Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Hikal Limited?

    Shares of Hikal Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Hikal Limited's key executives?

    Hikal Limited's management team includes the following people:

    • Mr. Sameer Hiremath MD & Director(age: 51, pay: $45,530,000)
  • How many employees does Hikal Limited have?

    As Jul 2024, Hikal Limited employs 2,142 workers.

  • When Hikal Limited went public?

    Hikal Limited is publicly traded company for more then 23 years since IPO on 1 Jul 2002.

  • What is Hikal Limited's official website?

    The official website for Hikal Limited is hikal.com.

  • How can i contact Hikal Limited?

    Hikal Limited can be reached via phone at +91 22 3097 3100.

Hikal Limited company profile:

Hikal Limited

hikal.com
Exchange:

NSE

Full time employees:

2,061

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Great Eastern Chambers
Navi Mumbai, 400614

:
ISIN: INE475B01022
CUSIP: Y3195T157